Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
30
RBB Quote, Financials, Valuation and Earnings
Last price:
$20.85
Seasonality move
:
-5.14%
Day range:
$20.66 - $21.49
52-week range:
$16.49 - $25.30
Dividend yield:
3.05%
P/E ratio:
11.35x
P/S ratio:
3.26x
P/B ratio:
0.73x
Volume:
41.1K
Avg. volume:
47.5K
1-year change:
5.11%
Market cap:
$371.6M
Revenue:
$134.3M
EPS (TTM):
$1.85
Analysts' Opinion
-
Consensus RatingRBB Bancorp has received a consensus rating of . The company's average rating is a based on 0 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $24.70, RBB Bancorp has an estimated upside of 17.62% from its current price of $21.00.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $23.00 representing 100% downside risk from its current price of $21.00.
Fair Value
-
According to the consensus of 0 analysts, RBB Bancorp has 17.62% upside to fair value with a price target of $24.70 per share.
RBB vs. S&P 500
-
Over the past 5 trading days, RBB Bancorp has underperformed the S&P 500 by -11.71% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
RBB Bancorp does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
RBB Bancorp revenues have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter RBB Bancorp reported revenues of $30.3M.
Earnings Growth
-
RBB Bancorp earnings have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter RBB Bancorp reported earnings per share of $0.39.
Enterprise value:
50.5M
EV / Invested capital:
0.06x
Price / LTM sales:
3.26x
EV / EBIT:
0.31x
EV / Revenue:
0.42x
PEG ratio (5yr expected):
--
EV / Free cash flow:
1.60x
Price / Operating cash flow:
12.26x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.87%
Net Income Margin (TTM):
28.86%
Return On Equity:
6.74%
Return On Invested Capital:
4.22%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $155.2M | $142.6M | $119M | $30.4M | $30.3M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $3.20 | $2.53 | $1.85 | $0.45 | $0.39 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $393.9M | $722.5M | $441M | $685.8M | $655.7M | |
| Total Assets | $3.4B | $3.8B | $3.9B | $4.1B | $4B | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.9B | $3.3B | $3.4B | $3.6B | $3.5B | |
| Total Equity | $421.4M | $456M | $471.8M | $502.5M | $509.7M | |
| Total Debt | $308.5M | $337.3M | $428.1M | $338.9M | $334.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $103.7M | $82.6M | $32.2M | $25.3M | $24.5M | |
| Cash From Investing | -$281.2M | -$17.7M | $91.4M | $83.6M | -$32.8M | |
| Cash From Financing | -$25.2M | $91.7M | -$105M | -$24.4M | $104.9M | |
| Free Cash Flow | $101.7M | $81.4M | $31.6M | $25.3M | $24.2M | |
RBB
Sector
Market Cap
$371.6M
$694.8M
Price % of 52-Week High
83%
87.67%
Dividend Yield
3.05%
2.22%
Shareholder Yield
9.73%
3.87%
1-Year Price Total Return
5.11%
7.29%
Beta (5-Year)
0.962
0.737
Dividend yield:
3.05%
Annualized payout:
$0.64
Payout ratio:
34.65%
Growth streak:
3 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$22.24
200-day SMA
Buy
Level
$20.67
Bollinger Bands (100)
Sell
Level
21.84 - 23.86
Chaikin Money Flow
Buy
Level
2.1M
20-day SMA
Sell
Level
$23.18
Relative Strength Index (RSI14)
Sell
Level
25.86
ADX Line
Sell
Level
19.93
Williams %R
Buy
Level
-90.5947
50-day SMA
Sell
Level
$23.41
MACD (12, 26)
Sell
Level
-0.59
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Neutral
Level
3.7M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-1.989)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.
Stock Forecast FAQ
In the current month, RBB has received 0 Buy ratings 5 Hold ratings, and 0 Sell ratings. The RBB average analyst price target in the past 3 months is $24.70.
-
Where Will RBB Bancorp Stock Be In 1 Year?
According to analysts, the consensus estimate is that RBB Bancorp share price will rise to $24.70 per share over the next 12 months.
-
What Do Analysts Say About RBB Bancorp?
Analysts are divided on their view about RBB Bancorp share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that RBB Bancorp is a Sell and believe this share price will drop from its current level to $23.00.
-
What Is RBB Bancorp's Price Target?
The price target for RBB Bancorp over the next 1-year time period is forecast to be $24.70 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is RBB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for RBB Bancorp is a . 0 of 0 analysts rate the stock a at this time.
-
How Can I Buy Shares Of RBB?
You can purchase shares of RBB Bancorp via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase RBB Bancorp shares.
-
What Is The RBB Bancorp Share Price Today?
RBB Bancorp was last trading at $20.85 per share. This represents the most recent stock quote for RBB Bancorp. Yesterday, RBB Bancorp closed at $21.00 per share.
-
How To Buy RBB Bancorp Stock Online?
In order to purchase RBB Bancorp stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.51% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.76% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.86% over the past day.
